Articles: 1-10 of 553

Les lignes directrices définitives du CEPMB sur le prix des médicaments brevetés entrent en vigueur le 1er janvier 2026 : ce que cela signifie pour les entreprises pharmaceutiques innovantes

Canada - December 18 2025 À compter du 1er janvier 2026, le Conseil d’examen du prix des médicaments brevetés (CEPMB) mettra en œuvre de nouvelles Lignes directrices pour la…

Patent Infringement Damages Can Extend to Products Beyond Scope of Claims

Canada - December 16 2025 In a recent decision relating to a discovery dispute, the Federal Court of Canada (2025 FC 1916) affirmed that section 55(1) of the Patent Act does…

Open Banking 2025: Read, Write, and Rewrite the Rules

Canada - November 25 2025 As we have written about previously (here, here, here and here), the journey toward open banking (also called consumer driven banking) in Canada has…

Move It, Move It: Amendments to PIPEDA Add Data Mobility

Canada - November 19 2025 On November 4, 2025, the federal government tabled Bill C-15, an Act to implement certain provisions of Budget 2025. Among its proposed amendments to…

Dealing a New Hand: Federal Court Gives Card Game Patent a Second Chance

Canada - November 18 2025 On November 12, 2025, the Federal Court set aside the Commissioner of Patents’ refusal to grant a patent for a “Method of Playing a Card Game” (2025…

Budget 2025 Maintains Momentum in Financial Services Industry Reform

Canada - November 7 2025 On November 4, 2025, the Canadian federal government announced a number of legislative measures in Budget 2025 aimed at the financial services sector…

Ctrl+Alt+Bank: Canada Reboots Open Banking with Budget 2025

Canada - November 7 2025 Not to be missed from the federal governme…

Budget 2025 includes tax incentives to promote investment and innovation in Canada

Canada - November 5 2025 On November 4, 2025, Canada’s Minister of Finance and National Revenue, François-Philippe Champagne, tabled the Liberal Government’s Federal Budget…

Budget 2025 proposes to introduce federal stablecoin legislation

Canada - November 5 2025 As anticipated, the federal government has announced in Budget 2025 its intention to regulate the issuance of fiat-backed stablecoins in Canada. The…

Streamlined Biosimilar Approvals: What the End of Biosimilar Phase III Trials Means for Innovative Pharmaceutical Patent Holders

Canada, USA - November 3 2025 The U.S. Food and Drug Administration (FDA) has released a landmark draft guidance on biosimilar submission requirements (the “draft guidance”, link…